Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Survival Follow-up of Stage II/II Breast Cancer Patients Receiving PG2 Combination With Adjuvant Chemotherapy

NCT07601113 is registered in ClinicalTrials.gov with Kun-Ming Rau as lead sponsor.

NCT NCT07601113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07601113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Survival Follow-up of Stage II/II Breast Cancer Patients Receiving PG2 Combination With Adjuvant Chemotherapy
Lead sponsor
Kun-Ming Rau
Phase
Observational
Overall status
Completed
Start date
May 27, 2026
Completion date
June 30, 2026
Enrollment
66 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

survival